v3.22.2.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 277,592 $ 245,197
Investments in marketable securities 77,108 237,299
Accounts receivable 52,303 52,672
Inventories 13,272 26,818
Prepaid expenses and other current assets 38,264 34,848
Total current assets 458,539 596,834
Operating lease right-of-use assets, net 29,871 20,586
Property and equipment, less accumulated depreciation of $23,337 and $19,882 at September 30, 2022 and December 31, 2021, respectively 32,449 42,496
In-process research & development 23,000 23,000
Goodwill 197,797 197,797
Other non-current assets 17,872 24,427
Total Assets 759,528 905,140
Current liabilities:    
Accounts payable 12,046 21,513
Accrued expenses and other current liabilities 125,235 98,153
Contingent consideration payable 19,833 18,900
Operating lease liabilities 7,536 7,409
Total current liabilities 164,650 145,975
Long-term debt 391,319 389,357
Operating lease liabilities 52,012 43,363
Deferred reimbursements 5,906 5,906
Deferred income taxes 4,930 4,930
Other non-current liabilities 8,146 8,240
Total liabilities 626,963 597,771
Commitments and contingencies
Stockholders’ equity:    
Common stock, $0.01 par value, 500,000,000 shares authorized, 280,887,136 and 278,912,800 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 2,813 2,808
Additional paid-in capital 2,645,372 2,595,419
Accumulated other comprehensive (loss) gain:    
Foreign currency translation adjustment (38,724) 5,251
Unrealized loss on available-for-sale securities (354) (270)
Warrants 83 83
Accumulated deficit (2,476,625) (2,295,922)
Total stockholders’ equity 132,565 307,369
Total Liabilities and Stockholders’ Equity $ 759,528 $ 905,140